These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32460810)

  • 1. The effect of primary tumor radiotherapy in patients with Unresectable stage IV Rectal or Rectosigmoid Cancer: a propensity score matching analysis for survival.
    Wang G; Wang W; Jin H; Dong H; Chen W; Li X; Li G; Li L
    Radiat Oncol; 2020 May; 15(1):126. PubMed ID: 32460810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative radiotherapy for rectal and rectosigmoid cancer: the impact of total dose on local control.
    Aleman BM; Lebesque JV; Hart AA
    Radiother Oncol; 1992 Nov; 25(3):203-6. PubMed ID: 1470697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of prognosis and influencing factors of No. 253 lymph node metastasis in descending colon, sigmoid colon, and rectal cancer: a multicenter study].
    Zhao FQ; Zhou L; Du XH; Wu AW; Yang H; Xu L; Liu XZ; Hu SD; Xiao Y; Liu Q
    Zhonghua Wai Ke Za Zhi; 2023 Sep; 61(9):760-767. PubMed ID: 37491168
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival Outcomes After Surgical Management of the Primary Tumor With and Without Radiotherapy for Metastatic Rectal Adenocarcinoma: A National Cancer Database (NCDB) Analysis.
    Renz P; Wegner RE; Hasan S; Brookover R; Finley G; Monga D; Raj M; McCormick J; Kirichenko A
    Clin Colorectal Cancer; 2019 Jun; 18(2):e237-e243. PubMed ID: 30905549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy treatment for isolated loco-regional recurrence of rectosigmoid cancer following definitive surgery: Peter MacCallum Cancer Institute experience, 1981-1990.
    Guiney MJ; Smith JG; Worotniuk V; Ngan S; Blakey D
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1019-25. PubMed ID: 9276368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence of Contact X-ray Brachytherapy (CXB) and External Beam Radiation (EBRT) in organ-preserving treatment for small rectal cancer.
    Than NW; Pritchard DM; Hughes DM; Duckworth CA; Wong H; Haq MU; Sripadam R; Myint AS
    Radiother Oncol; 2024 Oct; 199():110465. PubMed ID: 39074538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative irradiation after surgery for locally recurrent rectal cancer.
    Hashiguchi Y; Sekine T; Sakamoto H; Tanaka Y; Kazumoto T; Kato S; Sakura M; Fuse Y; Suda Y
    Dis Colon Rectum; 1999 Jul; 42(7):886-93; discussion 893-5. PubMed ID: 10411435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of rectal and sigmoid carcinoma patients receiving adjuvant chemoradiotherapy in Marmara University Hospital.
    Yumuk PF; Abacioglu U; Caglar H; Gumus M; Sengoz M; Turhal NS
    J Chemother; 2003 Dec; 15(6):603-6. PubMed ID: 14998088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
    Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
    Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monthly tegafur-uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: a retrospective study.
    Kuo YH; Lai CH; Huang CY; Chen CJ; Huang YC; Huang WS; Chin CC
    BMC Cancer; 2019 Aug; 19(1):815. PubMed ID: 31419963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Preoperative Radiation Therapy on Locoregional Recurrence in Patients with Stage IV Rectal Cancer Treated with Definitive Surgical Resection and Contemporary Chemotherapy.
    Manyam BV; Mallick IH; Abdel-Wahab MM; Reddy CA; Remzi FH; Kalady MF; Lavery I; Koyfman SA
    J Gastrointest Surg; 2015 Sep; 19(9):1676-83. PubMed ID: 26014718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of external beam radiotherapy alone for incompletely resected carcinoma of rectosigmoid or rectum: Peter MacCallum Cancer Institute experience 1981-1990.
    Guiney MJ; Smith JG; Worotniuk V; Ngan S
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):531-6. PubMed ID: 10078633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the impact of radiotherapy and surgical treatment regimens based on the SEER database on the survival outcomes of rectal cancer patients over 70 years.
    Wang W; Shen T; Wang J
    Math Biosci Eng; 2024 Feb; 21(3):4463-4484. PubMed ID: 38549336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectal NETs and rectosigmoid junction NETs may need to be treated differently.
    Cai W; Ge W; Hu H; Mao J
    Cancer Med; 2020 Feb; 9(3):971-979. PubMed ID: 31840409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incompletely resected rectum, recto-sigmoid, or sigmoid carcinoma: results of postoperative radiotherapy and prognostic factors.
    De Neve W; Martijn H; Lybeert MM; Crommelin M; Goor C; Ribot JG
    Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1297-302. PubMed ID: 1938527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Stahl JM; Ross R; Harder EM; Mancini BR; Soulos PR; Finkelstein SE; Shafman TD; Dosoretz AP; Evans SB; Husain ZA; Yu JB; Gross CP; Decker RH
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1011-1020. PubMed ID: 27869080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Duration of Neoadjuvant Radiation on Rectal Cancer Survival: A Real World Multi-center Retrospective Cohort Study.
    Abdel-Rahman O; Kumar A; Kennecke HF; Speers CH; Cheung WY
    Clin Colorectal Cancer; 2018 Mar; 17(1):e21-e28. PubMed ID: 28709877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer.
    Azria D; Bibeau F; Barbier N; Zouhair A; Lemanski C; Rouanet P; Ychou M; Senesse P; Ozsahin M; Pèlegrin A; Dubois JB; Thèzenas S
    BMC Cancer; 2005 Jun; 5():62. PubMed ID: 15967033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.